Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) Non Operating Investment Income: 2010-2016

Historic Non Operating Investment Income for Northwest Biotherapeutics (NWBO) over the last 4 years, with Dec 2016 value amounting to -$5.7 million.

  • Northwest Biotherapeutics' Non Operating Investment Income rose 97.85% to $1.4 million in Q4 2012 from the same period last year, while for Dec 2012 it was $2.0 million, marking a year-over-year increase of 170.05%. This contributed to the annual value of -$5.7 million for FY2016, which is N/A change from last year.
  • Northwest Biotherapeutics' Non Operating Investment Income amounted to -$5.7 million in FY2016, which was down 1,045.09% from $601,000 recorded in FY2012.
  • Northwest Biotherapeutics' 5-year Non Operating Investment Income high stood at $601,000 for FY2012, and its period low was -$5.7 million during FY2016.
  • For the 1-year period, Northwest Biotherapeutics' Non Operating Investment Income averaged around -$5.7 million, with its median value being -$5.7 million (2016).
  • Data for Northwest Biotherapeutics' Non Operating Investment Income shows a maximum YoY dropped of 17.45% (in 2012) over the last 5 years.
  • Northwest Biotherapeutics' Non Operating Investment Income (Yearly) stood at $601,000 in 2012, then followed by -$5.7 million in 2016.